BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
78 hedge funds and large institutions have $672M invested in BELLUS Health Inc. in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 24 closing their positions.
138% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 13
55% more call options, than puts
Call options by funds: $2.57M | Put options by funds: $1.66M
8% less capital invested
Capital invested by funds: $727M → $672M (-$55.1M)
12% less funds holding
Funds holding: 89 → 78 (-11)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
42% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$39.8M |
| 2 |
CC
Commodore Capital
New York
|
+$16.2M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$8.18M |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$8.05M |
| 5 |
DM
Deerfield Management
New York
|
+$7.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$48M |
| 2 |
Millennium Management
New York
|
-$19.9M |
| 3 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$7.63M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$3.86M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$3.62M |
BLU Hedge Fund Activity: Q1 2022 in Review
78 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q1 2022, worth a combined $672M — down 7.6% from $727M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of BLU and 14 opened new positions — a net loss of 10 holders — while 13 trimmed existing stakes and 31 added.
The largest buyer was Goldman Sachs, adding an estimated $39.8M. The largest seller was RTW Investments, exiting entirely with an estimated $48M sold.
- 78 institutional investors held BELLUS Health Inc. (BLU) as of Q1 2022, down from 89 in Q4 2021.
- Funds reported $672M of BELLUS Health Inc. stock for Q1 2022, down 7.6% quarter-over-quarter.
- 14 funds opened new BELLUS Health Inc. positions in Q1 2022 and 24 closed out, a net change of -10 holders.
- The largest BELLUS Health Inc. buyer in Q1 2022 was Goldman Sachs, an estimated $39.8M added.
- The largest BELLUS Health Inc. seller in Q1 2022 was RTW Investments, an estimated $48M sold.
Based on aggregated 13F filings for Q1 2022.